Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-03-04 @ 11:54 PM
Study NCT ID:
NCT01160718
Status:
COMPLETED
Last Update Posted:
2019-05-15
First Post:
2010-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy
Sponsor:
Swiss Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | estrogen receptor-positive breast cancer | View |
| None | HER2-positive breast cancer | View |
| None | HER2-negative breast cancer | View |
| None | progesterone receptor-positive breast cancer | View |
| None | recurrent breast cancer | View |
| None | stage IIIA breast cancer | View |
| None | stage IIIB breast cancer | View |
| None | stage IIIC breast cancer | View |
| None | stage IV breast cancer | View |